Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
Remon, J., Besse, B., Aix, S. Ponce, Callejo, A., Al-Rabi, K., Bernabe, R., Greillier, L., Majem, M., Reguart, N., Monnet, I., Cousin, S., Garrido, P., Robinet, G., Garcia Campelo, R., Madroszyk, A., Mazières, J., Curcio, H., Wasąg, B., Pretzenbacher, Y., Fournier, B., Dingemans, A.-M.C., Dziadziuszko, R.
Published in Annals of oncology (01.05.2023)
Published in Annals of oncology (01.05.2023)
Get full text
Journal Article
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer
Moutafi, Myrto K, Molero, Magdalena, Martinez Morilla, Sandra, Baena, Javier, Vathiotis, Ioannis A, Gavrielatou, Niki, Castro-Labrador, Laura, de Garibay, Gorka Ruiz, Adradas, Vera, Orive, Daniel, Valencia, Karmele, Calvo, Alfonso, Montuenga, Luis M, Ponce Aix, S, Schalper, Kurt A, Herbst, Roy S, Paz-Ares, Luis, Rimm, David L, Zugazagoitia, Jon
Published in Journal for immunotherapy of cancer (01.08.2022)
Published in Journal for immunotherapy of cancer (01.08.2022)
Get full text
Journal Article
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
Zugazagoitia, J., Ramos, I., Trigo, J.M., Palka, M., Gómez-Rueda, A., Jantus-Lewintre, E., Camps, C., Isla, D., Iranzo, P., Ponce-Aix, S., García-Campelo, R., Provencio, M., Franco, F., Bernabé, R., Juan-Vidal, O., Felip, E., de Castro, J., Sanchez-Torres, J.M., Faul, I., Lanman, R.B., Garrido, P., Paz-Ares, L.
Published in Annals of oncology (01.02.2019)
Published in Annals of oncology (01.02.2019)
Get full text
Journal Article
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study
Thomas, M., Ponce-Aix, S., Navarro, A., Riera-Knorrenschild, J., Schmidt, M., Wiegert, E., Kapp, K., Wittig, B., Mauri, C., Dómine Gómez, M., Kollmeier, J., Sadjadian, P., Fröhling, K -P, Huber, R.M., Wolf, M., Pall, Georg, Surmont, Veerle, Bosquee, Léon, Germonpré, Paul, Brückl, Wolfgang, Grah, Christina, Herzmann, Christian, Leistner, Rumo, Meyer, Andreas, Müller, Lothar, Schmalz, Oliver, Scholz, Christian, Schröder, Michael, Serke, Monika, Wesseler, Claas, Brandts, Christian, Kopp, Hans-Georg, Blau, Wolfgang, Griesinger, Frank, Campelo, Maria Rosario Garcia, Garcia, Yolanda Garcia, Perez, José Manuel Trigo
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
nab-paclitaxel + carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND.sqm study
Spigel, D.R., Jotte, R.M., Ponce Aix, S., Gressot, L., Morgensztern, D., McCleod, M., Socinski, M.A., Daniel, D., Juan-Vidal, O., Kim, E.S., West, H.J., Chen, T., Bhore, R., Ong, T.J., Gridelli, C., Thomas, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Maintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study
Thomas, M., Ponce Aix, S., Navarro Mendivil, A., Riera Knorrenschild, J., Schmidt, M., Wiegert, E., Kapp, K., Mauri, C., Domine Gomez, M., Kollmeier, J., Sadjadian, P., Fröhling, K.-P., Huber, R.M., Wolf, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer
Lin, C.-C., Taylor, M., Boni, V., Brunsvig, P.F., Geater, S.L., Salvagni, S., Garrido Lopez, P., Özgüroğlu, M., Sriuranpong, V., Ponce Aix, S., Ascierto, P.A., Fasolo, A., Sezer, A., Kowalski, D.M., Faris, J.E., Cameron, S., Mataraza, J., Wu, H., Antona, V., Ochoa de Olza, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase II results for single-agent nazartinib (EGF816) in adult patients (pts) with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC)
Tan, D.S., Kim, S.-W., Sequist, L.V., Ponce Aix, S., Smit, E.F., Hida, T., Yang, J.C.-H., Felip, E., Seto, T., Grohe, C., Wolf, J., Ko, J., Marriere, E., Belli, R., Giovannini, M., Kim, D.-W.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Carcinoma of unknown origin: Deep genomic profile helps to achieve an accurate diagnosis
Fernandez Díaz, A.B., Iranzo Gonzalez-Cruz, V., Cunquero Tomas, A.J., Avila Andrade, C., Jantus-Lewintre, E., Calabuig Fariñas, S., Ales, J.E., Valero, M., D'Errico, G., Pazo Cid, R.A., Gallego Martínez, A., Viana, A., Ponce Aix, S., Pérez-Fidalgo, J.A., Terradez, A., Rodrigo, A., Alvarez, L., Beniuga, G., Martorell, M., Camps, C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
191P Understanding and overcoming resistance to selective FGFR inhibitors across FGFR2-driven tumors
Facchinetti, F., Loriot, Y., Brayé, F., Vasseur, D., Bahleda, R., Bigot, L., Barbe, R., Nobre, C., Combarel, D., Michiels, S., Italiano, A., Smolenschi, C., Tselikas, L., Scoazec, J., Aix, S. Ponce, Besse, B., André, F., Olaussen, K.A., Hollebecque, A., Friboulet, L.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation
Schram, A.M., Lopes, G., El-Khoueiry, A.B., Fontana, E., Karasic, T.B., Kummar, S., Lorusso, P., Gregorc, V., Millward, M., Ponce Aix, S., Richardson, D.L., Roda Perez, D., Spira, A.I., Tan, D.S., Thompson, J.A., Uprety, D., Fellous, M., Qin, Y.G., Dumbrava, E.E.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
230TiP Exploring mechanisms of action and resistance in innovate cancer therapies: The UNLOCK program
Alonso de Castro, B., Rodriguez, J.E., Mosele, M.F., Nicotra, C., Camus, M. Ngo, Scoazec, J., Vasseur, D., Bigot, L., Nikolaev, S., Wang, J., Gerome, J-C., Brayé, F., André, F., Aix, S. Ponce, Massard, C.P., Italiano, A., Loriot, Y., Friboulet, L.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
PD-7 Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma (aHCC) and previously treated gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJ): Results of the COSMIC-021 study
Li, D., Loriot, Y., Burgoyne, A., Cleary, J., Santoro, A., Lin, D., Ponce Aix, S., Garrido-Laguna, I., Sudhagoni, R., Lougheed, J., Andrianova, S., Paulson, S.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article
1416P Recurrence of infusion-related reaction (IRRs) associated to avimantamab
Sanchez Becerra, M.V., Tagliamento, M., Aldea, M., Remon Masip, J., Gazzah, A., Vasseur, D., Lavaud, P., Frelaut, M., Abdayem, P., Meyer, M-L., Ghigna, M.R., Levy, A., Botticella, A., Ponce Aix, S., Barlesi, F., Planchard, D., Besse, B.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1161P Therapeutic outcome of molecular profiling of melanoma patients resistant to standard treatment: Real-world data
Sakkal, M., Aldea, M., Bayle, A., Vasseur, D., Routier, E., Belkadi-Sadou, D., Marchand, A., Gazzah, A., Smolenschi, C., Bahleda, R., Baldini, C., Champiat, S., Loriot, Y., Lacroix, L., Rouleau, E., Hollebecque, A., Italiano, A., Ponce Aix, S., Robert, C.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1050P Sensitization to immunotherapy through manipulation of tumor transcription by lurbinectedin
Russo-Cabrera, J.S., Ponce Aix, S., Cozar, P., Luengo, A., Navarro Mendivil, A.F., Bernabe Caro, R., Olmedo Garcia, M.E., Trigo Perez, J.M., Zugazagoitia, J., Paz-Ares, L., Otano Andres, I.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2300P Clonal hematopoiesis of indeterminate potential (CHIP) in patients with advanced NSCLC treated with immune checkpoint blockers (ICB) as monotherapy: Analysis of the PREMIS study
Rodriguez, J.E., Danlos, F-X., Larive, A., Marabelle, A., Frelaut, M., Tagliamento, M., Aldea, M., Besse, B., Micol, J. Baptiste, Aix, S. Ponce, Marzac, C., Chaput-Gras, N., Massard, C., Baldini, C.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1659P The use of liquid biopsy in patients with advanced pancreatic cancer (PDAC) to guide enrollment in phase I clinical trials
Letissier, O., Smolenschi, C., Hollebecque, A., Vasseur, D., Champiat, S., Bahleda, R., Gazzah, A., Michot, J-M., Danlos, F-X., Ouali, K., Henon, C., Mahjoubi, L., Goldschmidt, V., Loriot, Y., Massard, C., Bayle, A., Italiano, A., Baldini, C., Ponce Aix, S.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression
Andric, Z., Ceric, T., Rancic, M., Jakopovic, M., Ponce Aix, S., Ramlau, R., Ulanska, M., Caldwell, C., Ferrari, D., Annis, A., Vukovic, V., Zaric, B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1792P Molecular characterization from IMfirst: Atezolizumab plus chemotherapy in extensive-stage small cell lung cancer (ES-SCLC) in Spain
Cobo Dols, M., Dómine Gómez, M., de Castro Carpeño, J., Moreno Vega, A.L., Ponce Aix, S., Arriola Aperribay, E., Carcereny, E., Majem, M., Huidobro Vence, G., Esteban González, E., Fuentes Pradera, J., Ortega Granados, A.L.O., Guillot Morales, M., Massuti Sureda, B., Lianes Barragán, P., González Mancha, N., Fajardo, C.A., García Palacios, L., Lerones Laborda, N., García Campelo, M.R.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article